PTAB Denies Motion to Compel Discovery of Evidence from Parallel ITC Investigation Due to Lack of Inconsistency

October 29, 2024

Reading Time : 2 min

The PTAB denied a petitioner’s motion to compel routine discovery that sought information from a parallel ITC investigation for alleged inconsistent positions taken by patent owner in the IPR. The board found that patent owner had not taken inconsistent positions but warned patent owner that it had an ongoing duty to produce any information inconsistent with arguments made during the present IPR, even if that information related to arguments patent owner had dropped at the ITC.

The patent at issue related to gallium nitride (GaN) semiconductor devices. Petitioner alleged that patent owner was violating mandatory disclosure rules by not producing a textbook and expert testimony from the parallel ITC investigation that contained information inconsistent with patent owner’s IPR positions. Petitioner also argued that patent owner had to produce other non-public information that contained inconsistencies, including non-public exhibits in its ITC complaint, an expert report, and deposition transcripts.

The ITC information in question related to the role of hydrogen in GaN layers. Petitioner argued that the ITC arguments regarding the presence of hydrogen in a compensated GaN layer was inconsistent with patent owner’s IPR arguments. In response, patent owner explained that its ITC evidence showed that the GaN layer is compensated and contains hydrogen and magnesium, which was consistent with its IPR argument that “the mere presence of hydrogen is not enough to evidence a compensated GaN layer.” Patent owner also argued that the textbook produced in its ITC proceeding did not mention GaN at all, while its IPR arguments pertained specifically to GaN. Lastly, patent owner noted that demanding production of the textbook was unnecessary because petitioner could depose its expert on the textbook.

The board found that patent owner had not violated routine discovery rules and, in so finding, agreed that patent owner’s evidence was not inconsistent with its ITC positions. The board was also persuaded by patent owner’s certification under 37 CFR 42.51(b)(1)(iii) that it had investigated the potentially inconsistent information, and to the best of its knowledge, complied with its routine discovery obligations. The board explained that petitioner can still assert potentially inconsistent evidence, and any inconsistency would “serve to damage the credibility of [patent owner’s] arguments.” At this point however, the board found no such inconsistencies. Lastly, the board reminded patent owner that it has an ongoing duty to provide inconsistent information from the parallel ITC investigation, regardless of whether its position had changed in the interim.

Practice Tip: Parties in proceedings before the board have an ongoing duty under 37 C.F.R. § 42.51 to serve information inconsistent with a position taken in a parallel action. When faced with an allegation of withholding inconsistent information, parties must exercise diligence and investigate such claims to ensure satisfaction with the board’s evidentiary rules, especially when parties’ positions evolve in response to fact or expert discovery.

Innoscience Tech. Co., Ltd. v. Efficient Power Conversion Corp., IPR2023-01381, Paper 25 (August 8, 2024).

Share This Insight

Previous Entries

IP Newsflash

October 1, 2025

In a recent final written decision, the PTAB determined that a reference patent was not prior art, despite the petitioner’s post‑filing attempt to correct its petition. While the petitioner argued that it intended to rely on the patent application’s earlier date of publication, both the corrected petition and the expert declaration continued to reference the issued patent rather than the published application.

...

Read More

IP Newsflash

September 30, 2025

The USPTO Director recently granted a petitioner’s request for rehearing of the decision discretionarily denying institution of inter partes review, ultimately vacating the original decision, and referring the petition to the board for an institution decision.

...

Read More

IP Newsflash

September 25, 2025

In considering claims to a method of reducing cardiovascular events, the Federal Circuit held that the term a “clinically proven effective” amount did not render the claims patentable over the prior art. Specifically, the Federal Circuit held that the “clinically proven effective” amount, whether limiting or not, could not be used to distinguish the prior art because the claims also specified the exact amount of the drugs to be administered in the method. The Federal Circuit also rejected patentee’s evidence of unexpected results because that evidence was tied solely to the “clinically proven effective” limitation.

...

Read More

IP Newsflash

September 24, 2025

The Federal Circuit reversed a district court’s denial of judgment as a matter of law on non-infringement, thereby setting aside a $106 million jury verdict, after holding that prosecution history estoppel barred the patentee from asserting infringement under the doctrine of equivalents.

...

Read More

IP Newsflash

September 17, 2025

A magistrate judge in the District of Delaware issued a Report and Recommendation, that found the sole asserted claim was a “single means” claim and therefore invalid for lack of enablement. In reaching that conclusion, the magistrate judge rejected the patentee’s argument that the preamble of the claim disclosed a second element that satisfied the combination requirement of Section 112, paragraph 6 because the preamble simply recited a descriptor of the very apparatus that was the subject of the means-plus-function limitation in the body of the claim. The district court judge presiding over this case has scheduled a hearing to review the magistrate’s ruling.

...

Read More

IP Newsflash

September 9, 2025

The Federal Circuit has affirmed the PTAB’s determination that a patent challenger did not show the challenged claims were unpatentable for obviousness. The Federal Circuit concluded that substantial evidence, which included expert testimony, showed there was no motivation to combine the references.

...

Read More

IP Newsflash

August 29, 2025

In a recent order addressing four IPR proceedings, the PTAB exercised its inherent authority under 37 C.F.R. § 42.5(a) to sua sponte authorize post-hearing discovery on a potentially dispositive privity issue. The order followed a Director review decision that vacated and remanded earlier IPRs involving the same parties, patent family, and privity issue. 

...

Read More

IP Newsflash

August 29, 2025

The Patent Trial and Appeal Board denied institution of an inter partes review petition in part because it determined that a patent reference was not prior art under the common ownership exception of pre-AIA 35 U.S.C. § 103(c)(1).

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.